Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

Announcement on Lifting Sales Restrictions in the 1st Sales Restriction Period of Reserved Grant under the 2023 Restricted Stock Incentive Plan and Listing of Shares

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
The total number of shares to be listed and circulated this time is 190,000 shares; the listing and circulation date is September 4, 2025.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis